These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15548498)

  • 21. Rising mortality from motor neurone disease in Sweden 1961-1990: the relative role of increased population life expectancy and environmental factors.
    Neilson S; Gunnarsson LG; Robinson I
    Acta Neurol Scand; 1994 Sep; 90(3):150-9. PubMed ID: 7847054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
    Turner MR; Bakker M; Sham P; Shaw CE; Leigh PN; Al-Chalabi A
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):15-21. PubMed ID: 12061944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No Benefit of Diaphragm Pacing in Upper Motor Neuron-Dominant Forms of Amyotrophic Lateral Sclerosis.
    Morélot-Panzini C; Nierat MC; Tanguy ML; Bruneteau G; Pradat PF; Salachas F; Gonzalez-Bermejo J; Similowski T
    Am J Respir Crit Care Med; 2018 Oct; 198(7):964-968. PubMed ID: 29957023
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prognostic factors in amyotrophic lateral sclerosis].
    Martí-Fàbregas J; Pradas J; Illa I
    Neurologia; 1996 May; 11(5):174-81. PubMed ID: 8754633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing epidemiology of motor neurone disease in Scotland.
    Leighton DJ; Newton J; Stephenson LJ; Colville S; Davenport R; Gorrie G; Morrison I; Swingler R; Chandran S; Pal S;
    J Neurol; 2019 Apr; 266(4):817-825. PubMed ID: 30805795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
    Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
    J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
    Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
    Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor neurone disease and military service: evidence from the Scottish Veterans Health Study.
    Bergman BP; Mackay DF; Pell JP
    Occup Environ Med; 2015 Dec; 72(12):877-9. PubMed ID: 26468494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and prognostic features of ALS/MND in different phenotypes-data from a hospital-based registry.
    Wei QQ; Chen Y; Chen X; Cao B; Ou R; Zhang L; Hou Y; Shang H
    Brain Res Bull; 2018 Sep; 142():403-408. PubMed ID: 30232045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China.
    Chen L; Zhang B; Chen R; Tang L; Liu R; Yang Y; Yang Y; Liu X; Ye S; Zhan S; Fan D
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1075-81. PubMed ID: 26124198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience.
    Gordon PH; Salachas F; Lacomblez L; Le Forestier N; Pradat PF; Bruneteau G; Elbaz A; Meininger V
    Neurodegener Dis; 2013; 12(2):81-90. PubMed ID: 22922503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1258-61. PubMed ID: 12933930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.
    Chiò A; Calvo A; Bovio G; Canosa A; Bertuzzo D; Galmozzi F; Cugnasco P; Clerico M; De Mercanti S; Bersano E; Cammarosano S; Ilardi A; Manera U; Moglia C; Sideri R; Marinou K; Bottacchi E; Pisano F; Cantello R; Mazzini L; Mora G;
    JAMA Neurol; 2014 Sep; 71(9):1134-42. PubMed ID: 25048026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Living with amyotrophic lateral sclerosis/motor neurone disease (ALS/MND): decision-making about 'ongoing change and adaptation'.
    King SJ; Duke MM; O'Connor BA
    J Clin Nurs; 2009 Mar; 18(5):745-54. PubMed ID: 19239541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis.
    Fujimura-Kiyono C; Kimura F; Ishida S; Nakajima H; Hosokawa T; Sugino M; Hanafusa T
    J Neurol Neurosurg Psychiatry; 2011 Nov; 82(11):1244-9. PubMed ID: 21921087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G
    J Neurol Sci; 2008 May; 268(1-2):28-32. PubMed ID: 18021808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The natural history of primary lateral sclerosis.
    Gordon PH; Cheng B; Katz IB; Pinto M; Hays AP; Mitsumoto H; Rowland LP
    Neurology; 2006 Mar; 66(5):647-53. PubMed ID: 16534101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pronostic factors and survival in motor neuron disease].
    Larrode-Pellicer P; Alberti-González O; Iñiguez-Martínez C; Santos Lasaosa S; Pérez-Lázaro C; López del Val LJ
    Neurologia; 2007; 22(6):362-7. PubMed ID: 17610164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.